| scholarly article | Q13442814 |
| P50 | author | Rishi J Desai | Q87909236 |
| Daniel H Solomon | Q91503755 | ||
| P2093 | author name string | Katherine P Liao | |
| Seoyoung C Kim | |||
| Wesley Eddings | |||
| P2860 | cites work | Hydroxychloroquine Effects on Lipoprotein Profiles (the HELP trial): A Double-Blind, Randomized, Placebo-Controlled, Pilot Study In Patients With Systemic Lupus Erythematosus. | Q51576709 |
| Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study. | Q51695204 | ||
| Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
| Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. | Q53072910 | ||
| Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort | Q57658287 | ||
| Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis | Q79610823 | ||
| Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives | Q80981144 | ||
| Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 | ||
| Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments | Q30578515 | ||
| Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population | Q33765761 | ||
| Validation of rheumatoid arthritis diagnoses in health care utilization data | Q33827617 | ||
| Total cholesterol and LDL levels decrease before rheumatoid arthritis | Q33931317 | ||
| High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study | Q34090034 | ||
| Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death | Q34109979 | ||
| Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
| Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. | Q34514319 | ||
| A combined comorbidity score predicted mortality in elderly patients better than existing scores | Q35000472 | ||
| Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis | Q35547305 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy | Q36113215 | ||
| Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs | Q36361147 | ||
| Bias in research studies | Q36408241 | ||
| Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. | Q36901936 | ||
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 | ||
| Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma | Q37416965 | ||
| Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis | Q37977885 | ||
| Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications | Q41921823 | ||
| Inhibition of hepatic cholesterol biosynthesis by chloroquine | Q41924905 | ||
| Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. | Q41929433 | ||
| Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis | Q41932479 | ||
| Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients | Q41933145 | ||
| Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 | ||
| Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States | Q43962885 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis | Q44882366 | ||
| Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor. | Q46015999 | ||
| Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients | Q46810525 | ||
| Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
| P433 | issue | 4 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| hyperlipidemia | Q1079120 | ||
| P304 | page(s) | 457-466 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study | |
| P478 | volume | 67 |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q55208303 | Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. |
| Q31077662 | Comparative effectiveness research with administrative health data in rheumatoid arthritis |
| Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
| Q36162860 | Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process |
| Q33871929 | Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. |
Search more.